Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL-Reference-Cited by-同舟云学术

Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL

Published:2012-07-03 Issue:2 Volume:27 Page:305-314
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Lhermitte L,Ben Abdelali R,Villarèse P,Bedjaoui N,Guillemot V,Trinquand A,Libura M,Bedin A S,Petit A,Dombret H,Leverger G,Ifrah N,Hermine O,Macintyre E,Asnafi V

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012177.pdf

Reference53 articles.

1. Look AT . Molecular pathways in T-cell acute lymphoblastic leukemia: ramifications for therapy. Clin Adv Hematol Oncol 2004; 2: 779–780.

2. Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003; 101: 2693–2703.

3. Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 2003; 102: 1000–1006.

4. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75–87.

5. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005; 106: 274–286.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD117 expression predicted FLT3 mutation in T‐cell acute lymphoblastic leukemia;eJHaem;2024-02

2. IL7-receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK-inhibition;Blood;2023-04-06

3. FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD);Cancers;2022-05-17

4. Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets;Cancers;2022-04-08

5. Adenylate kinase 2 expression and addiction in T-ALL;Blood Advances;2021-02-01